CytoMed Therapeutics Limited
General ticker "GDTC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $18.9M (TTM average)
CytoMed Therapeutics Limited does not follow the US Stock Market performance with the rate: -28.3%.
Estimated limits based on current volatility of 4.1%: low 0.93$, high 1.01$
Factors to consider:
- Total employees count: 28 as of 2022
Short-term GDTC quotes
Long-term GDTC plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | SGD0.32MM |
| Operating Expenses | SGD4.84MM |
| Operating Income | SGD-4.52MM |
| Non-Operating Income | SGD0.59MM |
| Interest Expense | SGD0.02MM |
| R&D Expense | SGD2.18MM |
| Income(Loss) | SGD-3.93MM |
| Net Income(Loss)* | SGD-3.92MM |
| Stockholders Equity | SGD6.54MM |
| Assets | SGD7.98MM |
| Operating Cash Flow | SGD-3.70MM |
| Capital expenditure | SGD0.70MM |
| Investing Cash Flow | SGD0.93MM |
| Financing Cash Flow | SGD0.21MM |
| Earnings Per Share** | SGD-0.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.